Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients.

Wells, Alvin F; Edwards, Christopher J; Kivitz, Alan J; Bird, Paul; Guerette, Benoit; Delev, Nikolay; Paris, Maria; Teng, Lichen; Aelion, Jacob A

Wells, Alvin F; Edwards, Christopher J; Kivitz, Alan J; Bird, Paul; Guerette, Benoit; Delev, Nikolay; Paris, Maria; Teng, Lichen; Aelion, Jacob A.

Afiliação

Wells AF; Aurora Rheumatology and Immunotherapy Center, Franklin, WI, USA.
Edwards CJ; NIHR Clinical Research Facility, University Hospital Southampton, Southampton, UK.
Kivitz AJ; Altoona Center for Clinical Research, Duncansville, PA, USA.
Bird P; Department of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Guerette B; Global Medical Affairs, Amgen Inc., Thousand Oaks, CA.
Delev N; Clinical Development, Celgene Corporation, Summit, NJ.
Paris M; Global Medical Affairs, Amgen Inc., Thousand Oaks, CA.
Teng L; Global Medical Affairs, Amgen Inc., Thousand Oaks, CA.
Aelion JA; West Tennessee Research Institute, Jackson, TN, USA.

Rheumatology (Oxford) ; 61(3): 1035-1043, 2022 03 02.

Article em En | MEDLINE | ID: mdl-34100922

Assuntos

Antirreumáticos/uso terapêutico; Artrite Psoriásica/tratamento farmacológico; Talidomida/análogos & derivados; Método Duplo-Cego; Feminino; Humanos; Masculino; Inibidores da Fosfodiesterase 4; Talidomida/uso terapêutico

Palavras-chave

DMARDs; biological therapies; clinical trials and methods; cytokines and inflammatory mediators; spondylarthropathies (including psoriatic arthritis)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Artrite Psoriásica / Antirreumáticos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google